Arkolith/Insider Trading/IRD/Form 4

Foundation Fighting Blindness, Inc.

Director, 10% OwnerOpus Genetics, Inc. (IRD) · full profile →Form 4 · filed May 6, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 5, 2025Conversion(C)6.9M——9.5M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2025Conversion(C)7K——0

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578563-25-000238) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML